A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2015
Price : $35 *
At a glance
- Drugs Bimatoprost (Primary)
- Indications Alopecia
- Focus Therapeutic Use
- Sponsors Allergan
- 12 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 21 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Sep 2013 Planned End Date changed from 1 Apr 2015 to 1 Jan 2015 as reported by ClinicalTrials.gov.